Your browser does not support JavaScript or it may be disabled!
 India As It Happens
Rediff Labs will showcase innovative products that rediff is working on behind the scenes.
News   |   Images
Get Realtime News
on your webpage

About 997 results for "first pharma"

Deal clincher: Sun hoists its flag on domestic pharma landscape
Financial Express

Khaitan, Luthra and Amarchand back first Phase II approval in ...

Drug-makers Sun Pharma and Ranbaxy get the Competition Commission of India's (CCI) approval for their $4-billion merger announced in April 2014. However, this approval is subject to a condition that the drug-makers will have to modify the deal by ... Bar & Bench, 1 week ago

87 images for first pharma

DirectorsTalk, 3 days ago
EuroInvestor, 2 days ago
Business Standard, 4 days ago
KXXV-TV, 4 days ago
Sys-Con Media, 4 days ago
I Stock Analyst, 4 days ago
Business Standard, 2 days ago
Jutia Group, 6 days ago
NDTV Profit, 1 week ago
Sify, 1 week ago

Pharma may get impacted due to weak forex: Credit Suisse

For the first time in ten years the REER and the USD-INR have diverged. For companies, the competitiveness impact will appear over time, but the one-off impact is already visible. Indian pharma companies with 3-17 percent of sales in emerging ...
 Moneycontrol.com6 days ago

TrialScope's Latest Version of PharmaCM Supports European Clinical Trial Results Reporting

PR Newswire JERSEY CITY, N.J., Dec. 9, 2014 JERSEY CITY, N.J. The new EudraCT results reporting functionality is a first-to-market solution that enables clinical trial sponsors to convert results data formatted for US National Institutes of ...
 Digital Journal1 week ago TrialScope updates PharmaCM, now supports European results reporting  Center Watch1 week ago TrialScope releases latest version of PharmaCM platform to manage clinical trial results data  News-Medical.Net1 week ago India computes new formula to compensate clinical trial deaths  Economic Times1 week ago
Business Standard

CCI to decide on Sun-Ranbaxy deal by month-end: Ashok Chawla

This big ticket deal in the pharma space is also the first M&A transaction to have gone through public scrutiny amid concerns of adverse impact on fair competition in the market. MUMBAI: Competition Commission is likely to take the final decision in the $4 ...
 Economic Times1 month ago CCI approves Sun Pharma-Ranbaxy deal; creates India's largest pharma co  ZeeNews.com1 week ago CCI to take final call on Sun Pharma-Ranbaxy deal this month  Business Standard1 month ago CCI decision on Sun-Ranbaxy deal before month end, says Chawla  Business Standard1 month ago

First batch of Pharm.D pass-outs gets lucrative placements

Most of the well-known Pharm.D institutes and colleges in the country have successfully provided placements to the first batch of Pharm.D pass-outs, with some of them gearing up to find lucrative jobs in the market, thanks to the focus on ...
 PharmaBiz1 week ago
IndiaTV News

Vaccine for dengue in 2015: Sanofi Pasteur

As India deals with increasing number of dengue fever, pharma major Sanofi on Tuesday said that the world’s first vaccine against the mosquito-borne viral disease may be available by the second half of 2015. Sanofi Pasteur, the French drugmaker’s vaccine ...
 Asian Age1 month ago World's 1st dengue vaccine likely by 2015: Sanofi  Business Standard1 month ago World's First Dengue Vaccine Likely By 2015, Says Sanofi  Silicon India1 month ago Dengue drug can give Sanofi $1-bn India biz  Rediff.com1 month ago
Business Standard

US Congress to intensify probe on prices against Indian pharma firms

The price rise probe, against Sun Pharma, Dr Reddy's and others, is being viewed as first of its kind Digbijay Mishra | New Delhi November 19, 2014 Last Updated at 00:48 IST Related News US Congress to intensify probe on prices against Indian pharma firms The ...
 Business Standard1 month ago Wockhardt : Fresh price control to hit Abbott, GSK  4 Traders6 days ago India withdraws policy to cap nonessential pharma prices  Rediff.com2 months ago
Business Standard

Drug major Ranbaxy beats expectations, posts first profit in 6 quarters

Stock rose 6.11% to Rs 634.10 on the BSE on and also triggered a 4.31% rise in Sun Pharma, which is acquiring Ranbaxy in an all-stock deal worth $4 billion. NEW DELHI: Embattled drugmaker Ranbaxy Laboratories Ltd posted its first profit in six quarters on the ...
 Economic Times1 month ago Ranbaxy books first profit in six quarters, Q2 PAT at Rs 478 cr  Business Standard1 month ago
Hindustan Times

IT pharma shares help Sensex Nifty log first rise in 3 sessions

Indian markets on Thursday logged their first rise in three sessions with benchmark Sensex gaining 35 points to end at 2806756 and Nifty appreciating 20 points to close above 8400mark after IT and pharma shares held to late gains amid rupee breaching the ...
 Hindustan Times1 month ago IT, pharma shares help Sensex,Nifty log 1st rise in 3 sessions  Business Standard1 month ago

First launch in Algerian mkt seen in Q1FY16: Alembic Pharma

Once this deal is concluded, the company will be renamed as Alembic Mami SPA.
 Money Control1 month ago
Prev | Next
Personalize your Realtimeclose [x]
Add content to your personalized tab - My News
Add upto 6 topics of your interest:
for eg.2g Scam , World
Personalize the tabs display. ( You can add or remove the tabs )
AlertsGet updates on latest news & your favourite topics right in your inbox.Set an Alert|Manage your Alerts


Realtime News

on your Webpage

Add Widget >Get your members hooked!
Get updated on latest news & your favorite topics right in your inbox!
More     Less